KCR, a CRO operating in 19 European countries and the U.S., is relocating its head office from Warsaw, Poland, to Berlin, Germany. The new location will better serve its own customers and support the company’s expanding services and operations.

“This is an important step to further implement KCR’s business growth strategy,” said Mike Jagielski, president and CEO of KCR. “The establishment of a new head office in Berlin builds upon our previous decisions to strengthen the company’s footprint in Western Europe. Moving to Germany is a response to our clients’ expectations regarding KCR’s strong presence in Western Europe. It also will allow us to further diversify the KCR talent pool to support our customer focused approach.”

The head office in Berlin will serve as a management and business development center, whereas the office in Warsaw will continue to be the company’s operational hub. KCR European coverage includes entities in Western Europe in Austria, France and the U.K., as well as in Central and Eastern Europe and the Commonwealth of Independent States. Due to the project portfolio acquisition of Ukrainian CRO Axis, KCR recently has become one of the key players for trial execution in Ukraine.

“KCR continues to expand and enhance its capacities to provide our clients with successful, high-quality clinical development services. We believe that our new head office in Berlin will successfully corroborate our planned growth strategy for the years to come,” said Jagielski.